Profiles of chronic obstructive lung disease: Characteristics of stable chronic obstructive lung disease in different parts of Asia

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 2, 2014, Pages 165-172

  Bhome, Arvind B ^a   Brashier, Bill ^b  

^a Indian Coalition for the Study of Obstructive Lung Diseases   (India)

^b Chest Research Foundation   (India)

Author keywords

chronic obstructive lung disease characteristics; chronic obstructive lung disease in Asia; nonsmokers' chronic obstructive lung disease; phenotypes of chronic obstructive lung disease

Indexed keywords

AIR POLLUTION; ASIA; DEPRESSION; DISEASE SUSCEPTIBILITY; DUST; ENVIRONMENTAL EXPOSURE; FAMILY CHARACTERISTICS; HUMANS; OCCUPATIONAL EXPOSURE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SMOKING; THINNESS; VEHICLE EMISSIONS;

EID: 84894064661     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000033     Document Type: Review

References (53)

1. th January 2011. Available online: https://apps.who.int/infobase/Index.aspx. [Accessed 10 November 2013]. An important overview of the global mortality estimates and projections for the next couple of decades.
2. Bhome AB. COPD in India: iceberg or volcano? J Thorac Dis 2012;4:298-309.
3. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-2223. This is a must read for anyone who wants to understand the disease burden dynamics of 291 causes of disease and injuries expressed as DALYs in, 20 age groups, both sexes, 187 countries from 1990-2005 to 2010 in a global burden series capturing premature mortality, prevalence and severity of ill-health. The article is in a series of articles that has shaped global health policy over the last two decades and is a unique global collaboration spanning across all continents and most countries.
4. Lim SS, Vos T, Abraham D, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-2260. This is in the same league as [3] It quantifies disease burden - deaths and DALYs - in terms of 67 risk factors and their clusters causing those diseases of global significance. This exercise has been done comparing how these risks have changed with the changing disease profiles from 1990 to 2010. A must read for the clarity of understanding the global health issues and formulating the policy for prevention and mitigation.
5. Kurmi OP, Lam KBH, Ayres JG. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J 2012;40:239-254. This article is in a series on air pollution and lung disease of special importance, as it provides a comprehensive review of literature on indoor pollution and discusses issues relevant to understand the scattered literature on the subject with multiple variables. Although not Asia specific, it contains a very useful discussion on many Asian studies. A must read for anyone interested in nonsmokers' COPD.
6. Lam NL, Smith KR, Gauthier A. Kerosene: a review of household uses and their hazards in low and middle income countries. J Toxicol Environ Health B Crit Rev 2012;15:396-432.
7. Lam N, Chen Y, Weyant C, et al. Household light makes global heat: high black carbon emissions from kerosene wick lamps. Environ Sci Technol 2012;46:13531-13538.
8. McKay AJ, Mahesh PA, Fordham JZ, Majeed A. Prevalence of COPD in India: a systematic review. Prim Care Respir J 2012;21:313-321.
9. Tageldin MA, Nafti S, Khan JA, et al., BREATHE Study group. Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. Respir Med 2012;106(Suppl. 2):S25-S32.
10. Jindal SK, Aggarwal AN, Gupta D, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012;16:1270-1277.
11. Koul PA. Chronic obstructive pulmonary disease: Indian guidelines and the road ahead. Lung India 2013;30:175-177.
12. Brashier B, Londhe J, Madas S, et al. Prevalence of self-reported respiratory symptoms, asthma and chronic bronchitis in slum area of a rapidly developing Indian city. Open Journal of Respiratory Diseases 2012;2:73-81.
13. Yang G, Wang y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2013;381:1987-2015.
14. Kiyohara K, Kojimahara N, Sato Y, Yamaguchi N. Changes in COPD mortality rate after amendments to the Preventive Vaccination Law in Japan. Eur J Public Health 2013;23:133-139.
15. Global Adult Tobacco Study 2013. http://www.who.int/tobacco/surveillance/ gats/en/and http://www.who.int/tobacco/global-report/2013/en/index.html. [Accessed 30 November 2013]
16. Global Youth Tobacco Survey 2005. http://www.who.int/fctc/reporting/ Annexoneindia.pdf. [Accessed 30 November 2013]
17. Jawad M, Jawad S, Mehdi A, et al. A qualitative analysis among regular waterpipe tobacco smokers in London universities. Int J Tuberc Lung Dis 2013;17:1364-1369.
18. Boskabady MH, Farhang L, Mahmodinia M, et al. Comparison of pulmonary function and respiratory symptoms in water pipe and cigarette smokers. Respirology 2012;17:950-956.
19. Jawad M, Abass J, Hariri A, et al. Water-pipe smoking: prevalence and attitudes among medical students in London. Int J Tuberc Lung Dis 2013;17:137-140.
20. Abughosh S, Wu I-H, Peters RJ, et al. Ethnicity and water-pipe smoking among US students. Int J Tuberc Lung Dis 2012;16:1551-1557.
21. Khabour OF, Alzoubi KH, Eissenberg T, et al. Water-pipe tobacco and cigarette smoking among university students in Jordan. Int J Tuberc Lung Dis 2012;16:986-992.
22. Mahmud T, Bokhari SN, Aasim M. Comparison of frequency of undiagnosed chronic obstructive pulmonary disease in current or former tobacco smokers having ischaemic heart disease. Indian J Chest Dis Allied Sci 2012;54:111-116.
23. Auf RA, Radwan GN, Loffredo C, et al. Assessment of tobacco dependence in waterpipe smokers in Egypt. Int J Tuberc Lung Dis 2012;16:132-137.
24. Camp PG, Ramirez-Venegas A, Sansores RH. COPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican females. Eur Respir J 2013; doi: 10. 1183/09031936.00206112 [Epub ahead of print] This study tested nonsmoker biomass exposed COPD female patients and controlled matched ex-smoker COPD female patients never exposed to biomass fuel with CT functional imaging software and proved that biomass exposed COPD patients had very little emphysema (0.7 versus 2.3, P=0.001) and more airway wall thickening with air trapping (2.6 versus 1.5, P = 0.02) as compared with smoking-induced COPD patients, and also had lower symptom scores, hrQOL and more desaturation at rest and exercise (P < 0.05).
25. González-García M, Torres-Duque CA, Bustos A, et al. Bronchial hyperresponsiveness in women with chronic obstructive pulmonary disease related to woodsmoke. Int J Chron Obstruct Pulmon Dis 2012;7:367-373.
26. Oh YM, Bhome AB, Boonasawat W, et al. Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities. Int J Chron Obstruct Pulmon Dis 2013;8:31-39.
27. Sussan TE, Ingole V, Kim JH, et al. Source of biomass cooking fuel determines pulmonary response to household air pollution. Am J Respir Cell Mol Biol 2013. [Epub ahead of print] This animal exposure experiment by Indian and US researchers mimicked human exposuretowoodsmoke and cow-dungcakesbyreplicating thesameinmice tofirst establish the effect of acute exposure resulting in robust proinflammatory cytokine production, neutrophilic inflammation, airway resistance and hyper-responsiveness, all of which were higher in cow-dung exposed mice in comparison to wood smoke exposed. Asopposedtothis, subchronicexposureresultedinmore changesinwood smoke exposed mice than cow-dung exposed mice; and were characterized by eosinophilic inflammation, PM-specific antibody responses and alveolar destruction. Mechanisms that underlie this were studied by using mice deficient in 5 receptors [toll-like receptors (TLR)-2, 3, 4, 5 and IL-1R], of which three receptors were found to demonstrate inflammatory responses via My88 on exposure to wood smoke orcowdung, viz. IL-1R, TLR-4 and TLR-2. The authors conclude that subchronic exposure to PM collected from households burning biomass fuel elicits a persistent pulmonary inflammation largely through activation of TLR and IL-1R pathways, which could increase the risk for chronic respiratory diseases.
28. Uzaslan E, Mahboub B, Beji M, et al., BREATHE Study Group. The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med 2012;106(Suppl 2):S45-S59.
29. Shavro SA, Ezhilarasu P, Augustine J, et al. Correlation of health related quality of life with other disease indices in Indian chronic obstructive disease patients. Int J Chron Obstrct Pulmon Dis 2012;7:291-296.
30. Cao Y, Gong W, Zhang H, et al. A comparison of serum and sputum inflammatory mediator profiles in patients with asthma and COPD. J Int Med Res 2012;40:2231-2242.
31. Neopane A, Sharma L, Dulal S, et al. Value of sputum differential count in chronic obstructive airway disease. J Nepal Health Res Counc 2013;11:26-29.
32. Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:44-52. This recent study from the Hokkaido study shows the annual decline in FEV1-based classification into rapid, slow and nondecliners can be correlated with emphysema severity rather than FEV1%. DLCO also varied with emphysema severity and correlated well with CT changes. Rapid decliners were independently associated with CT-based or DLCO-based emphysema severity.
33. Chen LF, Wang CH, Chou PC, et al. Association between emphysema score, six-minute walk and cardiopulmonary exercise tests in COPD. Open Respiratory Medicine Journal 2012;6:104-110.
34. Fan L, Xia Y, Guan Y, et al. Characteristic features of pulmonary function test, CT volume analysis and MRperfusion imaging in COPD patients with different HRCT phenotypes. Clin Respir J 2013. [Epub ahead of print]
35. Kurashima K, Hoshi T, Takayanagi N, et al. Airway dimensions and pulmonary function in chronic obstructive pulmonary disease and bronchial asthma. Respirology 2012;17:79-86. Patients with COPD have wall thickness without narrowing from third to sixth generations of bronchi. Asthma patients have narrow airways, with fifth generation corresponding with FEV1 the most. Mixed asthma with emphysema patients had sixth-generation airways correlated best with pulmonary function.
36. Park BH, Park MS, Chang J, et al. Chronic obstructive pulmonary disease and metabolic syndrome: a nationwide survey in Korea. Int J Tuberc Lung Dis 2012;16:694-700.
37. Sekhar TVDS, Bokam B, Muppalla LL, et al. Comorbid conditions in patients with physician diagnosed COPD: data from a tertiary centre in South India. Int J Med Sci Public Health 2013;2:738-742.
38. Han D, Zhang Y, Li B, et al. Alexithymia in Chinese chronic obstructive pulmonary disease (COPD) patients: the prevalence and related factors of alexithymia. Psychiatry Res 2012;198:274-278.
39. Tsai TY, Livneh H, Lu MC, et al. Increased risk and related factors of depression among patients with COPD: a population-based cohort study. BMC Public Health 2013;13:976.
40. Sharma BB, Singh S, Sharma VK, et al. Psychiatric morbidity in chronic respiratory disorders in an Indian service using GMHAT/PC. Gen Hosp Psychiatry 2013;35:39-44.
41. Loerboks A, Jiang CQ, Thomas GN, et al. COPD and depressive symptoms: findings from the Guangzhou Biobank Cohort Study. Ann Behav Med 2012;44:408-415.
42. Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulmonary Medicine 2012;12:53.
43. Zhang L, Lou P, Zhu Y, et al. Impact of risk factors, activities and psychological disorders on the health of patients with chronic obstructive pulmonary disease in China: a cross-sectional study. BMC Public Health 2013;13:627.
44. Lu Y, Feng L, Feng L, et al. Systemic inflammation depression and obstructive lung function: a population-based study. Respir Res 2013;14:53.
45. Wang H, Yang L, Zou L, et al. Association between chronic obstructive pulmonary disease and lung cancer: acase-control studyin Southern Chinese and a meta-analysis. PLoS One 2012;7:e46144. doi:10.1371/journal. pone.0046144.
46. Zhang J, Zhou JB, Lin XF, et al. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population. Respirology 2013;18:297-302.
47. Yang L, Qiu F, Lu X, et al. Functional polymorphisms of CHRNA3 predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. PLoS One 2012;7:e46071. doi:10.1371/journal.pone.0046071. The authors wanted to test two single nucleotide polymorphisms (SNPs) (rs6495309 and rs1051730) located in nicotinic acetylcholine receptor α-3 (CHRNA3) gene in the Chinese population, to explore whether there exist common predictor risks for COPD and lung cancer as both diseases have a shared cause. The said SNPs were genotyped in 1511 COPD patients, 1559 lung cancer patients and 1677 controls in South and East China. They found that the rs6495309CC and rs6495309CT/CC variant genotypes were associated with increased risks of COPD (OR=1.32) and lung cancer (OR=1.57), respectively. The rs6495309CC genotype contributed to more rapid decline of annual FEV1 in both COPD cases and controls (P=0.05), and it was associated with advanced stages of COPD (P=0.033); the rs6495309CT/CC genotypes conferred a poor survival for lung cancer (hazard ratio= 1.41). The luciferase assays further showed that nicotine and other tobacco chemicals had diverse effects on the luciferase activity of the rs6495309C or T alleles. However, none of these effects were found for another SNP, rs1051730G A. The data show a statistical association and suggest biological plausibility that the rs6495309T C polymorphism contributed to the increased risks and poor prognosis of both COPD and lung cancer.
48. Kim WJ, Oh YM, Kim TH, et al. CHRNA3 variant for lung cancer is associated with chronic obstructive pulmonary disease in Korea. Respiration 2013;86:117-122. The authors wanted to explore the genetic predisposition of Korean people to COPD and to lung function decline and development of emphysema. They studied two SNPs (rs660652 and rs12910984) in 219 Korean Cohort Study on Obstructive Lung Disease COPD individuals and 305 controls. All patients were subjected to volumetric CT scans to quantify the emphysema severity. They found significant association between rs12910984 and COPD. There was no association with FEV1 or emphysema severity and genotypes among COPD patients, but there was significant association with DLCO.
49. Leung CC, Lam TH, Yew WW, et al. Obstructive lung disease does not increase lung cancer mortality among female never-smokers in Hong Kong. Int J Tuberc Lung Dis 2012;16:546-552.
50. Huang KW, Luo JC, Leu HB, et al. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide populationbased study. Aliment Pharmacol Ther 2012;35:796-802.
51. Kamble NL, Khan NA, Kumar N, et al. Study of gastro-oesophageal reflux disease in patients with mild-to-moderate chronic obstructive pulmonary disease in India. Respirology 2013;18:463-467.
52. Chiang YY, Lin HW. Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan. Eur Acad Dermatol Venereol 2012;26:59-65.
53. Rittayamai N, Chuaychoo B, Sriwijitkamol A. Prevalence of osteoporosis and osteopenia in Thai COPD patients. Med Assoc Thai 2012;95:1021-1027.